See more : Bristol-Myers Squibb Company (BRM.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Talkspace, Inc. (TALK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Talkspace, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Auxico Resources Canada Inc. (AUAG.CN) Income Statement Analysis – Financial Results
- Public Joint Stock Company “Cherkizovo Group” (GCHE.ME) Income Statement Analysis – Financial Results
- Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Income Statement Analysis – Financial Results
- Sun-Life Holding Co.,Ltd. (7040.T) Income Statement Analysis – Financial Results
- Youngbo Chemical Co., Ltd. (014440.KS) Income Statement Analysis – Financial Results
Talkspace, Inc. (TALK)
About Talkspace, Inc.
Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. The members can send text, video, and voice messages to their therapists and engage in live video sessions. Talkspace, Inc. is based in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 150.05M | 119.57M | 113.67M | 76.19M | 38.18M |
Cost of Revenue | 75.67M | 59.23M | 46.90M | 26.35M | 18.04M |
Gross Profit | 74.38M | 60.34M | 66.77M | 49.84M | 20.14M |
Gross Profit Ratio | 49.57% | 50.46% | 58.74% | 65.41% | 52.74% |
Research & Development | 17.57M | 21.66M | 15.92M | 9.58M | 12.00M |
General & Administrative | 21.32M | 36.27M | 34.77M | 10.20M | 5.36M |
Selling & Marketing | 52.54M | 72.84M | 100.64M | 47.71M | 27.54M |
SG&A | 73.86M | 109.11M | 135.41M | 57.90M | 32.90M |
Other Expenses | 6.16M | 6.59M | 9.37M | 4.33M | 4.67M |
Operating Expenses | 97.59M | 137.36M | 160.70M | 71.82M | 49.56M |
Cost & Expenses | 173.25M | 196.59M | 207.59M | 98.17M | 67.61M |
Interest Income | 4.25M | 3.74M | 31.23M | 0.00 | 350.00K |
Interest Expense | 0.00 | 3.74M | 0.00 | 364.00K | 0.00 |
Depreciation & Amortization | 1.20M | 1.36M | 1.97M | 379.00K | 59.00K |
EBITDA | -22.01M | -78.06M | -84.56M | -21.60M | -29.37M |
EBITDA Ratio | -14.67% | -58.15% | -80.89% | -28.35% | -76.93% |
Operating Income | -23.21M | -77.02M | -93.92M | -21.98M | -29.43M |
Operating Income Ratio | -15.47% | -64.42% | -82.63% | -28.85% | -77.08% |
Total Other Income/Expenses | 4.25M | -2.39M | 31.23M | -364.00K | 350.00K |
Income Before Tax | -18.96M | -79.42M | -62.70M | -22.35M | -29.08M |
Income Before Tax Ratio | -12.64% | -66.42% | -55.15% | -29.33% | -76.16% |
Income Tax Expense | 218.00K | 254.00K | 47.00K | 24.00K | 8.00K |
Net Income | -19.18M | -79.67M | -62.74M | -22.37M | -29.09M |
Net Income Ratio | -12.78% | -66.63% | -55.20% | -29.36% | -76.19% |
EPS | -0.12 | -0.51 | -0.72 | -1.67 | -0.56 |
EPS Diluted | -0.12 | -0.51 | -0.72 | -1.67 | -0.56 |
Weighted Avg Shares Out | 165.04M | 156.89M | 86.78M | 13.36M | 51.75M |
Weighted Avg Shares Out (Dil) | 165.04M | 156.89M | 86.78M | 13.36M | 51.75M |
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025
Small Caps Are Winners of 2024: 5 Picks With Solid Short-Term Upside
Talkspace to Participate in 3rd Annual Needham Virtual Health Tech Conference
Trump Wins: 3 Stocks Poised to Benefit (PLTR, TSLA, TALK)
Talkspace: Jumpstarting Momentum As Payor Programs Expand
Talkspace, Inc. (TALK) Q4 2024 Earnings Call Transcript
Talkspace Shares Decline Despite Partnership With Wisdo Health
Talkspace to Report Third Quarter 2024 and Host Conference Call
Talkspace: Payor Penetration Driving Key Growth
Talkspace Recognized as one of Crain's 2024 Best Places to Work in NYC
Source: https://incomestatements.info
Category: Stock Reports